PBI21 TRENDS IN AUTHORIZATIONS AND PRICES OF BIOSIMILAR PRODUCTS IN THE US

Abstract

Authors

M. Jamjoom E. Seoane-Vazquez H. Althobaiti

Full Text Cite This Article
Back to Volume 23, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×